A rapid immunoassay for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, Influenza Type A and Type B antigen from nasopharyngeal swab specimens. Flocked nasopharyngeal swab for superior specimen collection and patient comfort.
Real-time PCR test for specific detection of SARS-CoV-2, including the variants alpha (B.1.1.7 lineage), beta (B.1.351 lineage), gamma (P.1 lineage), delta (B1.617.2 lineage), lambda (C.37 lineage), mu (B.1.621 lineage) and omicron (B.1.1.529 lineage)
Provides the comprehensive reagents, components, materials required to simplify the collection, transport, storage, and detection of SARS-CoV-2. The solution allows biospecimens to be taken from the collection sites and transported to the hospitals and reference labs where viral RNA is extracted and detected by RT-PCR assays.
The nucleocapsid (N) is a major structural protein of SARS-CoV-2. It is highly conservative, providing an ideal marker for immunodiagnosis. Fapon self-developed monoclonal antibodies have high sensitivity, specificity, and batch-to-batch consistency, with no cross-reactivity with other pathogens (human coronaviruses, flu, pneumonia, etc.). Different application scenarios are supported with stable bulk
COVID-19 Coronavirus and Influenza A/B virus Real-Time PCR Kit are an In Vitro Diagnostic (IVD) reagent relying on fluorescent PCR technology for the qualitatively detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and/or influenza B virus from upper and lower respiratory tract samples.
The Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit from Bioperfectus is an in vitro diagnostic test used for the detection of novel coronavirus (SARS-CoV-2) IgM and IgG antibodies. This product is based on immunochromatographic technology. The detection area of the strip has an IgM test line (T2 line),
COVID-19 Coronavirus Real-Time PCR Kit is an In Vitro Diagnostic (IVD) reagent applying fluorescent PCR technology and aiming to qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens.
Rapid chromatographic immunoassay (lateral-flow) for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.(Catalog Number: SC30107W)
This kit is used for the qualitative detection of novel coronavirus IgG antibodies in human serum or plasma in vitro.
Principle: This kit is based on the capture ELISA method to detect the SARS-COV-2 IgM antibody in human serum or plasma. The anti-µ chain monoclonal antibody is pre-coated
This kit is used for the quantitative detection of novel coronavirus IgG antibodies in human serum or plasma in vitro.
Principle: This kit is based on the indirect method (ELISA) principle to detect the SARS-COV-2 IgG antibody in human serum or plasma. The SARS-COV-2 whole virus lysate antigen is
Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike is used to test the ability of serum, antibodies, and drugs to neutralize the infectivity of SARS-CoV2 spike protein. Pseudovirus display an antigenically-correct spike protein pseudotyped on replication-incompetent virus particles that contain a heterologous lentiviral (HIV) core.
Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike is capable of
PrimeStore® MTM is a molecular transport media that gives the user a “snapshot” in time for that sample by preserving and stabilizing DNA and RNA.
PrimeStore® MTM (Molecular Transport Medium) was designed and optimized for molecular testing allowing pathogenic samples to be collected, transported,
Bio-Shield 2019-nCoV Total Immunoglobulins, is a semi-quantitative ELISA test for the determination of IgA, IgM, IgG antibodies against SARS-CoV-2 in human serum or plasma (Heparin, EDTA or Citrate) specimens.
Helix Elite™ Synthetic RNA molecular standard is intended for use as a positive control in molecular applications for SARS-CoV-2. The SARS-CoV-2 synthetic RNA material is a 1044-nucleotide portion of the SARS-CoV-2 N (nucleocapsid) gene. It contains three markers N1, N2 and N3 that are commonly used in diagnostic assays.